Quantitative determination and localization of cathepsin D and its inhibitors

Folia Histochemica et Cytobiologica

Volumn 47, Issue 2, 2009, Pages 153-177

  Minarowska, Alina ^a   Karwowska, Alicja ^a   Gacko, Marek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Activity; Cathepsin D; Cathepsin D inhibitors; Cell distribution; Concentration; Tissue distribution

Indexed keywords

ALBUMIN; ALPHA GLOBIN; BETA ENDORPHIN; BETA GLOBIN; CASEIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN D INHIBITOR; CATHEPSIN L; HEMOGLOBIN; MYOGLOBIN; PEPSTATIN; PROCATHEPSIN D; PROTEIN INHIBITOR; SOMATOMEDIN B RECEPTOR; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

CELLULAR DISTRIBUTION; COLORIMETRY; CONCENTRATION PROCESS; DENATURATION; DIAGNOSTIC VALUE; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR MECHANICS; NONHUMAN; PH; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; REVIEW; SPECTROPHOTOMETRY; TISSUE DISTRIBUTION; TISSUE HOMOGENATE;

EID: 73549114458     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0073-4     Document Type: Review

References (236)

1. [ 1] Ochmaru E, Sakai H, Saku T, Kunimatsu K, Kato Y, Kato I, Yamamoto K. Characterization of hemoglobin-hydrolyzing and proteinases in human and rat neutrophils. J Biochem. 1990;108:1009-1015.
2. [ 2] Yamoto K. Cathepsin E and cathepsin D, w: Proteases. New perspectives, red. V Turk. Birkhauser Verlag, Basel. 1999:59-71.
3. [ 3] Blott EJ, Griffithis GM. Secretory lysosomes. Nature Rev. 2002;3:122-131.
4. [ 4] Worowski K, Mariak T. Metody pomiaru aktywnooeci enzymów proteolitycznych. Diagn Lab. 1973;9:219-232.
5. [ 5] Barrett AJ. Cathepsin D and other carboxyl proteinases, in: Proteinases in mammalian cell and tissue ed. AJ Barrett. Nort-Holland Publ Comp, Amsterdam. 1977:209-248.
6. [ 6] Lanoe J, Dumnigan J. Improvements of the Anson assay for measuring proteolytic activities in acidic pH range. Anal Biochem. 1978;89:461-471.
7. [ 7] Worowski K, Ostrowska H. Cathepsin D. Post Biol Kom. 1980;7:119-147.
8. [ 8] Sarth G, de la Motte RS, Wagner FW. Protease assay methods, in Proteolytic enzymes a practical approach, ed. RJ Beynon, JS Bond. IRL Press, Oxford. 1994:25-55.
9. [ 9] Reis RCM, Sorgine MHF, Coelho-Sampaio T. A novel methodology for the investigation of intracellular proteolytic processing in intact cells. Eur J Cell Biol. 1998;75:192-197.
10. Roszkowska-Jakimiec W, Worowska A, Gacko M, Worowski K. Determination of activity and concentration of cathepsin and their inhibitors. Diagn Lab. 2000;36:103-119.
11. Greczaniuk A, Roszkowska-Jakimiec W, Gacko M, Worowska A. Oznaczanie aktywnooeci katepsyny D w osoczu krwi przy użyciu hemoglobiny zdenaturowanej kwasem solnym. Diagn Lab. 2001;36:97-101.
12. Roszkowska-Jakimiec W, Gacko M, Worowska A. Method of cathepsin D activity and concentration determination. Diagn Lab. 2007;43:275-282.
13. Richo GR, Conner GE. Structural requirements of procathepsin D activation and maturation. J Biol Chem. 1994;296:14806-14812.
14. Mullins C, Bonifacino JS. The molecular machinery for lysosom biogenesis. BioEssays. 2001;23:333-343.
15. Minarowska A, Gacko M, Karwowska A, Minarowski Ł. Human cathepsin D. Folia Hisochem Cytobiol. 2008;46:23-38.
16. Erickon AH. Biosynthesis of lysosomal endopeptidases. J Cell Biochem. 1989;40:31-41.
17. Krishman V, Narasimahan TR, Safe S. Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cabcer cells. Anal Biochem. 1992;204:137-142.
18. Dahmus NH, Label P, Kornfeld S. Mamose 6-phosphate receptors and lysosomal enzyme tergeting. J Biol Chem. 1989;264:12115-12118.
19. Larsen LB, Boisen A, Petersen TE. Procathepsin D cannot autoactivate to cathepsin D at acid pH. FEBS Lett. 1993;319:54-58.
20. Wittlin S, Rosel J, Hofmann F, Stover DR. Mechanism and kinetics of procathepsin D activation. Eur J Biochem. 1999;265:384-393.
21. Wright LM, Levy ES, Patel NP, Alhadeff JA. Purification and characterization of cathepsin D for human breast tissue. J Prot Chem. 1997;16:171-181.
22. Bazel S, Ferry KV, Shoarinejd F, Laury-Kleintop LD, Lange MK, Tachovsky T, Longo S, Tucker S, Alhadeff JA. Analysis of breast tissue cathepsin D isoforms from patients with breast cancer, benign disease and from normal controls. Int J Oncol. 1994;5:847-853.
23. van Noort JM, van der Drift ACM. The selectivity of cathepsin D suggests an involvement of the T-cell epitopes. J Biol Chem. 1989;264:14159-14164.
24. Cunningham M, Tang J. Purification and properties of cathepsin D from porcine spleen. J Biol Chem. 1972;251: 4528-4536.
25. Naduwimana J, Guenet L, Dorval I, Blayau M, Le Gall JY, Le Treut A. Proteases. Ann Biol Clin. 1995:251-264.
26. Cuervo AM, Paulmer A, Rivett AJ, Knecht E. Degradation of proteasomes by lysosomes in rat liver. Eur J Biochem. 1995;227:792-800.
27. Bohley P, Seglen PO. Proteases and proteolysis in the lysosome. Experientia. 1992;48:151-157.
28. Diment S, Leech MS, Stahl PD. Cathepsin D is membraneassociated in macrophage endosomes. J Biol Chem. 1988;263:6901-6907.
29. Lim SK, Ferraro B, Moore K, Halliwell B. Role of haptoglobin in the hemoglobin metabolism. Redox Report. 2001;6:219-227.
30. Kimura H, Tsudzuki T, Murachi T. Proteolytic degradation of hemoglobin-haptoglobin complex by lysosomal enzymes from rat liver. J Biochem. 1975;77:909-912.
31. Kramar R, Lambrechter R, Raab W. Die katheptiche aktivitat im harn. Wien Klin Wschr. 1970;82:410-411.
32. Dean RT, Barrett AJ. Essays in biochemistry ed. PN Campbell WN Aldrige. Acad Press NY. 1976;12:1-40.
33. Esumi H, Sato S, Sugimura T, Okasaki N. Purification and properties of an acid protease from human asciric fluid. Biochim Biophys Acta. 1978;523:191-197.
34. Raab WP. Diagnostic value of urinary enzyme determination. Clin Chem. 1972;18:5-25.
35. Ostrowska H, Worowski K. Blood platelets - a source of cathepsin D activity in the serum. Acta Haematol Pol. 1982;13:13-16.
36. De Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J. 1955;60:604-617.
37. Karwowoska A, Gacko M, Worowska A, Krupkowska A; Tissue fragmentation for biochemical studies. Bromat Chem Toksycol. 2006;39:199-202.
38. Panusz H. The influence of autolysis and homogenization techniques on the stability of preparations of subcellular fractions. Ann Acad Med Lodzensis. 1973;14,suppl.10:157-161.
39. Ladinsky H, Consolo S, Sanvito A. Simple appartus for pulverization and rapid quantitative transfer of frozen tissue. Anal Biochem. 1972;49:294-297.
40. Obenauf RH. SPEX CertiPrep handblook of sample preparation and handling. SPEX GertiPrep Inc Metuchen NJ USA. 2002:26-54.
41. Wiśniewska-Knypl JM, Knobloch K, Jabłońska J, Ruta U. Decrease of tissue respiration, activity of oxoglutarate dehydrogenase and level of sulfhydryl groups in acute acrylonitrile intoxication in rats. Med Pracy. 1970;21:544-549.
42. Chyczewski L, Płoński A, Chyczewska E, Furman M, Ostrowska H, Niklinacute;ski J, Kozłowski M. Activity and tissue localization of cathepsin D in non small cell lung cancer. Ann Acad Med Bialostoc. 1997;42suppl1:217-229.
43. McIntyre GF, Erickson AH. Procathepsin L and D are membrane-bound in acidic microsomal vesicles. J Biol Chem. 1991;266:15438-15445.
44. Beaufay H. Methods for the isolation of lysosomes, in lysosomes a laboratory handbook, ed JT Dindle. North-Holland Publ Comp Amsterdam. 1972:1-32.
45. Leeighton F, Paole B, Beaufay H, Baudhuin P, Coffey JW, Fowler S, de Duve C. The large-scale separation of peroxisomes, mitochondria, and lysosomes from the livers of rats injected with triton WR-1339. J Cell Biol. 1968;37:482.
46. Storrie B, Madden EA. Isolation of subcellular organelles. Meth Enzymol. 1990;182:203-225.
47. Gacko M, Głowiński J, Skrzydlewska E, Worowska A, Głowiński S. Activity of enzymes of varions subcellular localization in cytosol obtained after cell organelle precipitation at pH 5,0. Ann Acad Med Białostocensis. 1996;41:341-346.
48. Sznajd J, Naskalski J. Determination of the activity of enzyme inactivated during catalytic process. Diagn Lab. 1978;14:127-133.
49. Turk V, Lah T, Kregar I. Cathepsin D, cathepsin E. In ed HU Bergmeyer Methods of enzymatic analysis. Verlag Chemie Weinheim. 1984:211-222.
50. ]50] Reijngoud DJ, Tager JM. Measurement of intralysosomal pH. Biochem Biophys Acta. 1973;297:174-179.
51. Okhuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cell and the perturbation of pH by various agents. Proc Natt acad Sci USA. 1978;75:3327-3331.
52. Van Dyke RW. Acidification of rat liver lysosomes: quantitation and comparision with endosomes. Am J Physiol. 1993;165:C901-C917.
53. Koelsch G, Mares M, Metcalf P, Fusek M. Multiple function of pro-parts aspartic proteinase zymogenes. FEBS Lett. 1994;343:6-10.
54. Masa M, Maresova L, Vondrasek J, Horn M, Jezek J, Mares M. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalitic core. Biochemistry. 2006;45:15474-15482.
55. Shamberger RJ. Lysosomal enzyme changes in growing and regressing mammary tumors, Biochem J. 1969;111:375-383.
56. Marciniszyn J, Hartsuch JA, Tang J. Mode od inhibition of acid proteases by pepstatin. J Biol Chem. 1976;25:7088-7094.
57. Ducastaing A, Azanza JL, Raymund J, Robin JM, Greach P. La cathepsin D de rate de cheval. II. Etude de quelques properietes enzymatique. Biochemie. 1972;58:783-791.
58. Zuhlsdorf M, Imort M, Hasilik A, Von Fidura K. Molecular forms of beta-hexosaminidase and cathepasin D in serum and urine of health subjects and patients with elevated acticity of lysosomal enzymes. Biochem J. 1983;213:733-740.
59. Zwierz K, Zych J. Concentration of the biological fluids. Diagn Lab. 1971;7:127-130.
60. Ciba J. Poradnik chemika analityka. Wyd N-T Warszawa. 1989;1:107.
61. Lee AY, Gulnik SV, Erickson JW. Conformational switching in an aspartic proteinase. Nat Struct Biol. 1998;5:866-871.
62. Kageyama T. Molecular cloning, expression and characterization of an Ascaris inhibitor for pepsin and cathepsin E. Eur J Biochem. 1998;253:804-809.
63. Brinkworth RI, Prociv P, Loukas A, Brindley PJ. Hemoglobin-degradation, aspartic proteases of blood-fleeding parasites: substrate specificity revealed by homology models. J Biol Chem. 2001; 276:38844-38851.
64. Wharton SA, Hipkiss AR. Degradation of peptidase and proteins of different size by homogenates of human MRC5 lung fibroblasts. FEBS Lett. 1985;184:249-253.
65. Fruitier I, Gareau I, Piat JM. Cathepsin D is a good candidate for the specific release of stable hemorphin from hemoglobin in vivo: VV-hemorphin - 7. Biochem Biophys Res Commun. 1998;246:719-724.
66. Manning JM, Dumoulin A, Li X, Manning LR. Normal and abnormal protein subunit interaction in hemoglobins. J Biol Chem. 1998;173:19359-19362.
67. Geraci G, Parkhurst LJ, Gibson QH. Preparation and properties of alfa- and beta-chains human hemoglobin. J Biol Chem. 1969;244:46664-4667.
68. Wojtowicz MB, Odense P. The effect of urea upon the activity measurement of cod muscle cathepsin with hemoglobin substrate. Can J Biochem. 1970;48:1050-1053.
69. Rossi Fanelli A, Antonini A, Caputo A; Hemoglobin and myoglobin. Adv Protein Chem. 1964;19:74-222.
70. Wiederanders B, Kirschke H, Scharper S. The azocaseinurea-pepstatin assay discriminates between lysosomal proteinases. Biomed. Biochim. Acta. 1986;45:1477-1483.
71. Rossi-Fanelli A, Antonioni E, Caputo A. Studies on the structure of hemoglobin. I. Physiococchemical properties of human globin. Biochem Biophys Acta. 1958;30:608-615.
72. Winterhalter KH, Huehns ER. Preparation, properties and specific recombination of alpha-beta-globin subunits. J Biol Chem. 1964;239:3699-3702.
73. Hu T, Li DX, Su ZG. Preparation and characterization of dimeric bovine hemoglobin tetramers. J Prot Chem. 2003;22:411-416.
74. Knook DL, Steyster EC. Isolated parenchymal, Kupfter and endothelial rat liver cells charactericed by their lysosomal enzyme content. Biochem Biophys Res Commun. 1980;96:250-257.
75. Chrastil J. Spectrophotometric determination of tryptophan and tyrosine in peptides and proteins based on new color reactions. Anal Biochem. 1986;158:443-446.
76. Balasubramanin K, Deiss WP. Characterictics of thyroid lysosomal cathepsin. Biochem Biophys Acta. 1965;110:564-575.
77. Marrink J, Gruber M. Use of casein in assays for proteolytic activity in tissue extracts: a warning. Biochim Biophys Acta. 1966;118:438-439.
78. Lapresle C, Webb T. Study of a proteolytic enzyme from rabbit spleen. Biochem J. 1960;76:538-549.
79. McDonald CE, Chen LL. The Lowry modyfication of the Folin reagent for determination of proteinase activity. Anal Biochem. 1965;10:175-177.
80. Mednis A, Remold HG. A sensitive fluorometric assay for the determination of cathepsin D. Anal Biochem. 1972;49:114-138.
81. Rakoczy PE, Lai CM, Baines M, Di Grandi S, Fitton JH, Constable IJ. Modulation of cathepsin D activity in retinal pigment epithelial cells. Biochem J. 1997;324:935-940.
82. Opresko L, Wiley HS, Wallace RA. Proteins iodinated by chloramine-T method appear to be degraded at an abnormally rapid rate ofter endocytosis. Proc Natt Acad Sci USA. 1980;77:1556-1560.
83. Azaryan A, Akopyan T, Buniatian H. Cathepsin D from human brain: purification and multiple froms. Biomed Biochim Acta. 1983;42:1237-1246.
84. De Lumen BO, Tappel AL. Fluorescein-hemoglobin as a substrate for cathepsin D and other proteases. Anal Biochem. 1970;36:22-29.
85. Schwabe C. Afluorescent assay for proteolytic enzymes. Anal Biochem. 1973;53:484-490.
86. Bohley P, Stein S, Darman W, Udenfriend S. Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys. 1973;155:213-220.
87. Twining SS. Fluoroescein isothiocynate laboled casein assay for proteolytic enzyme. Anal Biochem. 1984;143:30-34.
88. Hortin GL, Warshawsky I, Laude-Sharp M. Macromolecular chromogenic substrates for measuring proteinase activity. Clin Chem. 2001;47:215-222.
89. Garesse R, Castell JV, Vallejo CG, Marco R. Afluorescamine-based sensitive method for the assay of proteinases, capable of detecting the initial cleavage step of a protein. Eur J Biochem. 1979;99:253-259.
90. Roth JS, Losty T, Wierbicki E. Assay of proteolytic enzyme activity using a 14C- labelled hemoglobin. Anal Biochem. 1971;42:214-221.
91. Williams HR, Lin TY. Methyl-14C-glycinated hemoglobin as a substrate for proteases. Biochim Biophys Acta. 1971;250:603-607.
92. Tack BF, Dean J, Eilat D. Tritium labelling of proteins to high specific radioactivity by reductive methylation. J Biol Chem. 1980;193:265-272.
93. Kageyama T, Moriyama A, Kato T, Sano M, Yonezawa S. Determination of cathepsin S and E in various tissues and cell of rat, monkey, and man by the assay with beta-endorphin and substrate P as substrate. Zool Sci. 1996;13:693-698.
94. Pennington RJ, Roninsosn JE. Cathepsin activity in normal and dystrophic human muscle. Enzym Biol Clin. 1968;9:175-182.
95. Adams CA, Robberts TC, Butler KC. Automated determination of proteolytic enzymes and of amino nitrogen by use of trinitrobenenesulfonic acid (TNBS). Anal Biochem. 1976;70:181-186.
96. Gan ZB, Marquardt RR, Xiao H. Protease and protease inhibitor assays using biotinylated casein coated on a solid phase. Anal Biochem. 1999;268:151-156.
97. Visconti J, Pasternak K, Jodłowska-Jȩdrych B, Pedrycz A, Łopucki M, Szranke M, Hawryluk J, Czerny K, Da̧browski W, Chichacz-Kwiatkowski B, Koziej J. Activity of cathepsin D and L in placentas from physiological and preterm deliveries as well as IUGR prognancies. Polich J Environ Stud. 2008;17:175-180.
98. Langer J, Ansorge S, Bohley P, Kirschke H, Hanson H. Intracellular protein breakdown. I. Activity determination of endopeptudases using protein substrates. Acta Biol Med Germ. 1971;26:935-951.
99. Kucharz E. A modified micromethod for determination of cathepsin activity in blood serum. Z Med Labor Diagn. 1984;25:282-284.
100. Chavira R. Burnett TJ, Hageman JH. Assaying proteinases with azocoll. Anal Biochem. 1984;136:446-450.
101. Sapolsky AJ, Altman RD, Woessner JF, Howell DS. The action of cathepsin D in human articular cartilage on proteoglycans. J Clin Invest. 1973;52:624-633.
102. Sapolsky AJ, Howell DS, Woessner JF. Neutral proteases and cathepsin D in human articular cartilage. J Clin Invest. 1974;53:1044-1074.
103. Pałka J, Bańkowski E, Worowski K. Susceptibility of different types of collagen to the action of cathepsin D. Ann Acad Med Biaslostoc. 1984;29:53-58.
104. Meybaum-Katzenellenbogen W, Kołaczkowska M. The use of tannin of the examination of the digestion process of casein and fibrinogen by plazmin and for the preparation of the polypeptide and products of proteolysis. Acta Physiol Pol. 1970;21:235-242.
105. Koshy PT, Rowan AD, Life PF, Cawston TE. 96-well plate assays for measuring collagenase activity using 3H-acetylated collagen. Anal Biochem. 1999;275:202-207.
106. Fukal L, Kas J, Vodrazka Z. Servey of methods used for proteolytic enzymes activity determination. Biochem Clin Bohemoslov. 1985;14:109-120.
107. Ottesen M, Spector A. Acomparison of two proteinases from Bacillus subtilis. Comp Rend Trav Lab Carlsberg. 1960;32:6-68.
108. Keilova H. On the specifity and inhibition of cathepsin Dand B, in: Tissue proteinases, ed. AJ Barrett, JT Dingle. North-Holland Publ Comp, Amsterdam. 1971:45-67.
109. Smith RF. Contribution of histochemistry to the development of the proteolitic enzyme detection system in diagnostic medicine. J. Histochem Cytochem. 1983;31:199-209.
110. Voynick JM, Fruton JS. The comparative specificity of acid proteinases. Proc Natl Acad Sci USA. 1971;68:257-259.
111. Ferguson JB, Andrews JR, Voynick IM, Fruton JS. The specificity of cathepsin D. J Biol Chem. 1973;248:6701-6708.
112. Dingle JT, Dean RT. Lysosomes in biology and pathology. North-Holland Publ Co Amsterdam. 1975:193-249.
113. Fruton JS. The mechanism of the catalytic action of pepsin and related acid proteinases. Adr Enzymol. 1976;44:1-36.
114. Marks N, Benuck M, Hashim G. Specificity of brain cathepsin D: cleavage of model peptides containing the susceptible Phe-Phe regions of myelin basic protein. J Neurosci Res. 1980;5:217-223.
115. Agarwal N, Rich DH. An improved cathepsin-D substrate and assay procedure. Anal Biochem. 1983;130:158-165.
116. Kay J, Valler MJ, Dunn BM. Naturally-occurring inhibitors of aspartic proteinases. In: Proteinase inhibitors: medical and biological aspects, ed. Katunuma N. Japan Sci Soc Press Tokyo. 1983:201-210.
117. Pohl J, Baudys M, Kostka V. Chromophoric peptide substrates for activity determination of animal aspartic proteinases in the presence of their zymogens: a movel assay. Anal Biochem. 1983;133:104-109.
118. Dunn BM, Kammermann B, Mc Curry K. The synthesis, purification, and evaluation of a new chromophoric substrate for pepsin and other aspartyl proteases. Anal Biochem. 1984;138:68-73.
119. Dunn BM, Kay J. Design, synthesis and analysis of new synthetic substrates for the aspartic proteinases. Biochem Soc Transact. 1985;13:1041-1043.
120. Dunn BM, Jiminez M, Parten BF, Valler MJ, Rolph J, Kay J. A systematic series of synthetic chromophoric substrates for aspartic proteinases. Biochem J. 1986;237:899-906.
121. Jupp RA, Dunn BM, Jacobs JW, Vlasuk G, Arcuri KE, Weber DF, Perlow DS, Payne LS, Boger J, de Laszlo S, Chakravarty PK, ten Broeke J, Hangauer DG, Ondeyka D, Greenlee WJ, Kay J. The selectivity of statine-based inhibitors against various human aspartic proteinases. Biochem J. 1990;265:871-878.
122. Scarborough PE, Guruprasad K, Topham C, Richo GR, Conner GE, Blundell TL, Dunn BM. Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling. Prot Sci. 1993;2:269-276.
123. Bolger GT, Jaramillo J. Muscle aspartyl protease (cathepsin D) activity: delection using a chromo-phoric substrate and relation to wasting in DBA/2 mice implanted with leukemic L1210 tumor cells. Canad J Physiol Pharmacol. 1996;74:1141-1148.
124. Katwa LC, Tyagi SC, Campbell SE, Lee SJ, Cicila GT, Weber KT. Valvular interstitial cells express angiotensinogen and cathepsin D, and generate angiotensin peptides. Int J Biochem Cell Biol. 1996;28:807-821.
125. Reinharz A, Roth M. Studies on pituitary cathepsin D with artificial substrates. Enzyme. 1971;12:458-466.
126. Woessner JF. Acid proteases: structure, function and biology, ed. J. Tang. Plenum Press New York. 1977:313-327.
127. Orlowski M, Orlowski R, Chang JC, Wilk E, Lesser M. A sensitive procedure for determination of cathepsin D activity in alveolar and peritonal macrophages. Mol Cell Biochem. 1984;64:155-164.
128. Poe M, Wu JK, Lin TY, Bull NY, Slater EE. Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr- Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D. Anal Biochem. 1984;140:459-467.
129. Cumin F, Le-Nguyen D, Castro B, Menard J, Corvol P. Comperative enzymatic studies of human renin acting on pure natural or synthetic substrates. Biochim Biophys Acta. 1987;913:10-19.
130. Stammers DK, Dann JG, Harris CJ, Smith DR. Comparison of angiotensinogen and tetradecapeptide as substrates for human renin. Substrate dependence of the mode of inhibition of renin by a statine- containing hexapeptide. Arch Biochem Biophys. 1987;258:413-420.
131. Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Peyrat JP. Cathepsin B, L and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Canc Lett. 1995;96:267-275.
132. Couissi D, Dubois V, Remacle C, Schonne E, Trouet A. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17β-estradiol, tamoxifen and ICI 182,780. Clin Exp Metastasis. 1997;15:349-360.
133. Smith RE, Van Frank RM. The use of amino acid derivatives of 4-methoxy-b- naphthylamine for the assay and subcellular localization of tissue proteinases, w: Lysosomes in biology and pathology, ed. Dingle JT, Dean RT. North-Holland Publishing Co Amsterdam. 1975;4:193-249.
134. Bogitsh BJ, Kirshner KF. Schistosoma japonicum: ultra-structural localization of a hemoglobinase using mercury labelled pepstatin. Exp Parasitol. 1986;62:211-215.
135. Baldwin ET, Bhat TN, Gulnik S, Hosur MV, Sowder RC, Cachau RE, Collins J, Silva AM, Erickson JW. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc Natl Acad Sci. 1993;90:6796-6800.
136. Beyer BM, Dunn BM. Self-activation of recombinant human lysosomal procathepsin D at a newly engineered cleavage junction, "short" pseudocathepsin D. J Biol Chem. 1996;271:15590-15596.
137. Filippova IY, Lysogorskaya EN, Anisimova VV, Suvorov LI, Oksenoit ES, Stepanov VM. Fluorogenic peptide substrates for assay of aspartyl proteinases. Anal Biochem. 1996;234:113-118.
138. Gulnik SV, Suvorov LI, Majer P, Collins J, Kane BP, Johnson DG, Erickson JW. Design of sensitive fluorogenic substrates for human cathepsin D. FEBS Lett. 1997;413:379-384.
139. Peterson JJ, Meares CF. Cathepsin substrates as cleavable peptide linkers in bioconjugates, selected from a fluorescence quench combinatorial libray. Bioconjug Chem. 1998;9:618-626.
140. Verity CK, McManus DP, Brindley PJ. Developmental expression od cathepsin D aspartic protease in Schistosoma japonicum. Int J Parasitol. 1999;29:1819-1824.
141. Yasuda Y, Kageyama T, Akamine A, Shibata M, Kominami E, Uchiyama Y, Yamamoto K. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D. J Biochem. 1999;125:1137-1143.
142. Yonezawa H, Uchikoba T, Arima K, Kaneda M. Fluorogenic substrates for cathepsin D. Biosci Biotech Biochem. 1999;63:1471-1475.
143. Pimenta DC, Oliveira A, Juliano MA, Juliano L. Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin. Biochem biophys Acta. 2001;1544:113-122.
144. Komai T, Kawabata C, Amano M, Lee BR, Ichishima E. Todarepsin, a new cathepsin D from hepatopancreas of Japanese common squid (Todarodes pacificus). Biochem Physiol Part B. 2004;137:373-382.
145. Baechle D, Cansier A, Fischer R, Brandenburg J, Burster T, Driessen C, Kalbacher H. Biotinylated fluorescent peptide substrates for the sensitive and specific determination of cathepsin D activity. J Pept Sci. 2005;11:166-175.
146. Yokata S, Atsumi S. Immunoelectron microscopic localization. of cathepsin D in lysosomes of rat nerve. Histochemistry. 1983;79:345-352.
147. Lin TY, Williams HR. Inhibition of cathepsin D by syntetic oligopeptides. J Biol Chem. 1979;254:11875-11883.
148. Juliano MA, Filira F, Gobbo M, Rocchi R, Del Nery E, Juliano L. Chromogenic and fluorogenic glycosylated and acetylglycosylated peptides as substrates for serine, thiol and aspartyl protease. J Peptide Res. 1999;53:109-119.
149. Knight CG. Active-site titration of peptidases. Meth Enzymol. 1995;248:85-101.
150. Yonezawa H, Uchikoba T, Kaneda M. Determination of pepstatin-sensitive carboxyl proteases by using pepstatinyldansyldiaminopropane (dansyl-pepstatin) as an active site titrant. J Biochem. 1997;122:294-299.
151. Pole AR. Immunological studies of tissue proteinases. Sub-cell Biochem. 1981;8:311-356.
152. Tumminello FM, Leto G, Pizzolanti G, Candiloro V, Crescimanno M, Crosta L, Flandina C, Montalto G, Soresi M, Carroccio A, Bascone F, Ruggeri I, Ippolito S, Gebbia N. Cathepsin D, B and L circulating levels as prognostic markers of malignant progression. Anticanc Res. 1996;16:2315-2320.
153. Brouillet JP, Spyratos F, Hacene K, Fauque J, Freiss G, Dupont F, Maudelonde T, Rochefort H. Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D. Eur J Cancer. 1993;29A:1248-1251.
154. Gion M, Mione R, Dittadi R, Romanelli M, Pappagallo L, Capitanio G, Friede U, Barbazza R, Visona A, Dante S. Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer. Eur J Cancer. 1995;31A:671-677.
155. Weston PD, Poole AR. Antibodies to enzymes and their use, with specific reference to cathepsin D and other lysosomal enzymes. In: Lysosomes in biology and pathology, ed. Dingle JT. North Holland Elsevier Amsterdam. 1973;3:425-464.
156. Wildenthal K, Poole AR, Dingle JT. Influence of starvation on the activities and localization of cathepsin D and other lysosomal enzymes in hearts of rabbits and mice. J Mol Cell Cardiol. 1975;7:841-855
157. Kopitar-Jerala N, Turk V. A procathepsin D specific monoclonal antibody that recognizes procathepsin D but not cathepsin D. Immunol Lett. 1999;70:211-212.
158. Kopitar-Jerala N, Puizdar V, Berbic S, Zavasnik-Bergant T, Turk V. A cathepsin D specific monoclonal antibody. Immunol Lett. 2001;77:125-126.
159. Dingle JT, Barrett AJ, Weston PD. Cathepsin D. Characteristics of immunoinhibition and the confirmation of a role in cartilage breakdown. Biochem J. 1971;123:1-13.
160. Koj A. The effect of antibodies on activity of enzymes. Zesz Nauk UJ. 1976;435:55-66.
161. Shaheen RM, Miseljic S, Doering DL, Wittliff JL. Comparison of cathepsin D determinations in human carcinomas by enzyme immunoassay and immunoradiometric assay. J Clin Lab Anal. 1995;9:351-358.
162. Knook DL. The role of lysosomal enzymes in protein degradation in different types of rat liver cells. Acta Biol Med Germ. 1977;36:1747-1752.
163. Stauber WT, Gauthier F, Ong SH. Identification and possible regulation of muscle cell lysosomal protease activity by exogenous protease inhibitors. Acta Biol Med Germ. 1981;40:1317-1322.
164. Musi M, Tessitore L, Bonelli G, Kazakova OV, Baccino FM. Changes in rat liver immunoreactive cathepsin D after cycloheximide. Biochem Int. 1985;10:283-290.
165. Rogier H, Freiss MG, Cavalie-Barthez G, Garcia M, Pau B, Rochefort H, Paolucci F. Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues. Clin Chem. 1989;35:81-85.
166. Sakai H, Saku T, Kato Y, Yamamoto K. Quantitation and immunohistochemical localization of cathepsins E and D in rat tissues and blood cells. Biochim Biophys Acta. 1989;991:367-375.
167. Gohring UJ, Scharl A, Thelen U, Ahr A, Crombach G, Titius BR. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods. J Clin Pathol. 1996;49:57-64.
168. Kasper M, Lackie P, Haase M, Schuh D, Müller M. Immunolocalization of cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis. Virchows Arch. 1996;428:207-215.
169. Długosz A, Chosia M. Immunocytochemical evaluation of gastric mucosal cathepsin D in peptic ulcer. Pol J Pathol. 1998;49:77-82.
170. Mylonas J, Makovitzky J, Richer DU, Jeschke U, Briese V, Friese K. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Acta Histochem. 2003;105:245-252.
171. Matthews ITW, Decker RS, Knight CG. Bimane-labelled pepstatin, a fluorescent probe for the subcellular location of cathepsin D. Biochem J. 1981;199:611-617.
172. Decker RS, Crie JS, Poolet AR, Dingle JT, Wildenthal K. Resistance to ischemic damage in hearts of starved rabbits. Correlation with lysosomal alternations and delayed release of cathepsin D. Lab. Invest. 1980;43:197-2007.
173. Yamato S, Hirabayashi Y, Uematsu H, Sugihara H. Histoand cytochemical studies of cathepsin D using a specific inhibitor- pepstatin. J Histochem Cytochem. 1982;30:597-599.
174. Yamato S, Hirabayashi Y, Sugihara H. An improved procedure for the histochemical demonstration of cathepsin D by the mercury-labeled pepstatin method. Stain Technol. 1984;59:113-120.
175. Sato Y, Mukai K, Watanabe S, Gotoh M, Shimosato Y. The AMeX method a simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol. 1986;125:431-435.
176. Roger P, Montcourrier P, Maudelonde T, Brouillet JP, Pages A, Laffargue F, Rochefort H. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Human Pathol. 1994;25:863-871.
177. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577-580.
178. Arao J, Fukui H, Ono Y, Ueda Y, Chiba T, Fujimori T. Immunohistochemical localization of cathepsin D in colorectal tumors. Dis Colon Rectum. 2000;43:396-401.
179. Gonias SL, Pizzo SV. Conformation and protease binding activity of binary and ternary human alpha 2-macroglobulin-protease complexes. J Biol Chem. 1983;258:14682-14692.
180. Lah T, Vihar M, Turk V. Interaction of cathepsin D and pepsin with a2-macroglobulin. In: Aspartic proteinases and their inhibitors, ed. Kostka V. Walter de Gruyter Berlin. 1985:485-490.
181. Barrett AJ, Starkey PM. The interaction of a2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J. 1973;133:709-724.
182. Thomas DJ, Richards AD, Kay J. Inhibition of aspartic proteinases by a2-macroglobulin. Biochem J. 1989;259:905-907.
183. Witt I, Tritschler W, Bablok W. Alpha-2-macroglobulin: reference values in serum and plasma with a chromogenic substrate (chromozym TRY). J Clin Chem Biochem. 1981;19:877-878.
184. Cassiman JJ, Van Leuven F, Van der Schueren B, Van den Berghe H. Immunohistochemical localization of human a2-macroglobulin in connective tissue. Cell Tissue Res. 1980;213:301-310.
185. Gaspar A, Skosey JL, Sequeira W, Teodorescu M. Detection of a2-macroglobulin-associated proteases in the plasma of patients with rheumatoid arthritis. Clin Chem. 1984;30:1517-1522.
186. Barrett AJ, Starkey PM, Munn EA. The unique nature of the interaction of a2-macroglobulin with proteinases. In: Proteinases inhibitors, ed. Fritz H, Tschesche H, Greene LG, Truscheit E. Springer-Verlag Berlin. 1974:72-77.
187. Swenson RP, Howard JB. Characterization of alkylamine-sensitive site in a2-macroglobulin. Proc Natl Acad Sci USA. 1979;7614:4313-4316.
188. Blatrix C, Amouch P, Drouet J, Steinbuch M. Study on the plasmatic elimination of the a2-macroglobulin proteinase complexes. Path Biol. 1973;21:11-14.
189. Gacko M, Minarowska A, Karwowska A, Minarowski Ł. Cathepsin D inhibitors. Folia Histochem Cytobiol. 2007;45:291-313.
190. Karwowska A, Gacko M, Worowska A. Aktywność proteolityczna i hamowanie aktywnooeci katepsyny D przez z nasion soczewicy. Bromat Chem Toksykol. 2008;41:in press.
191. Karwowska A, Gacko M, Worowska M. Inhibition of pepsin activity and cathepsin D activity by seed extracts of plants consumed by human. Bromat Chem Toksykol. 2008;41:258-261.
192. Barrett AJ, Dingle JT. The inhibition of tissue acid proteinases by pepstatin. Biochem J. 1972;127:439-441.
193. Chang Y, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibitions (I50) of on enzymatic reaction. Biochem Pharmacol. 1973;22:3099-3108.
194. Tumminello FM, Bernacki RJ, Gebbia N, Leto G. Pepstatins: aspartic proteinase inhibitors having potential therapeutic applications. Med Res Rev. 1993;13:199-208.
195. Rakitzis ET. Kinetics of irreversible enzyme inhibition by an unstable inhibitor. Biochem J. 1974;141:601-603.
196. Chi CW, Lo SS, Tan FL, Zhang YS, Chu HM. Studies on the mung bean trypsin inhibitor. In: Proteins in biology and medicine, ed. Bradshaw RA, Hill RL, Tang J. Acad Press NY. 1982:341-362.
197. Worowski K, Gabrylewicz A, Roszkowska W, Bajko K. The action of potato inhibitors on activation of zymogen forms of digestive system proteases. Acta Hepato-Gastroenterol. 1979;26:413-416.
198. Oak MH, El Bedoui J, Anglard P, Schini-Kerth VB. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. Circulation. 2004;110:1861-1867.
199. Daems WT, Wisse E, Brederoo P. Residual bodies and cellular defecation. In: Lysosomes a laboratory handbook, ed. Dingle JT. North-Holland Publ Comp Amsterdam-London. 1972:183-189.
200. Holtzman E. Lysosomes. Plenum Press NY. 1989:25-92.
201. Nyquist SE, Acuff K, Mollenhauer HH. Residual bodies and their components. Biol Reproduct. 1973;8:119-124.
202. Loegering DJ, Kaplan JE, Saba TM. Correlation of plasma lysosomal enzyme levels with hepatic reticuloendothelial function after trauma. Proc Soc Exp Biol Med. 1976;152:42-46.
203. Leto G, Gebbia N, Rausa L, Tumminello FM. Cathepsin D in the malignant progression of neoplastic diseases (review). Anticanc Res. 1992;12:235-248.
204. Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications. Clin Exp Metastas. 2004;21:91-106.
205. Schwartz MK. Tissue cathepsin as tumor markers. Clin Chim Acta. 1995;237:67-78.
206. Wada T, Ohara H, Watanabe K, Kinoshita H, Yachi A. Autoradiographic study on the site of uptake of the haptoglobin-hemoglobin complex. J Reticuloendothel Soc. 1970;8:185-193.
207. Loegering DJ, Carr FK, Saba TM. Cathepsin clearance from the circulation and reticuloendothelial function. Exp Mol Pathol. 1977;27:277-283.
208. Mason MS, Wangensteen SL. The effects of purified cathepsin D infusions in intact animals. Am J Surg. 1977;134:278-282.
209. de Alaniz MJT, de Gomez Dumm IN, Brenner RR. Comparative studies regarding different ways of expression of enzymatic activity. Enzymologia. 1970;38:85-88.
210. Frei J. The meaning of enzyme activity measurements in human tissues. Enzymol Biol Clin. 1970;11:3-7.
211. Fiszer-Szafarz DNA and protein content as cellular biochemical parameters. A discussion with two examples: acid phosphatase and cathepsin D in rat liver and hepatoma and acid phosphatase in human breast normal tissue and adenocarcinoma. Anal Biochem. 1984;138:255-258.
212. Khamis Ali F, Roszkowska-Jakimiec W, Gacko M, Worowska A. Pepsin. Diag Lab. 1995;31:595-612.
213. Kay J, Tatnell PJ. Cathepsin E. In: Handbook of proteolytic enzymes, ed. Barrett AJ, Rawling ND, Woessner JF. Elsevier Amsterdam. 2004;1:33-38.
214. Zaidi N, Kalbacher H. Cathepsin E: a mini review. Biochem Biophys Res Commun. 2008;367:517-522.
215. Valler MJ, Kay J, Aoyagi T, Dunn BM. The interaction of aspartic proteinases with naturally-occurring inhibitors from actinomycetes and Ascaris lumbricoides. J Enzyme Inhib. 1985;1:77-82.
216. Ng KKS, Petersen JFW, Cherney MM, Garen C, Zalatoris JJ, Rao-Naik C, Dunn BM, Martzen MR, Peanasky RJ, James MNG. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3. Nat Struct Biol. 2000;7:653-657.
217. Lombardo A, Caimi L, Marchesini S, Goi GC, Tettamanti G. Enzymes of lysosomal origin in human plasma and serum: assay conditions and parameters influencing the assay. Clin Chim Acta. 1980;108:337-346.
218. Leto G, Tumminello FM, Pizzolanti G , Montalto G, Soresi M, Ruggeri I, Gebbia N. Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and/or liver cirrhosis. Eur J Clin Chem Clin Biochem. 1996;34:555-560.
219. Leto G, Tumminello FM, Pizzolanti G , Montalto G, Soresi M, Carroccio A, Ippolito S, Gebbia N. Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas. 1997;14:22-27.
220. Molina E, Ramos M, Cifuentes A, Lopez-Fandino R. Characterization of cheese proteolysis by capillary electrophoresis and reverse-phase HPLC analyses of peptides. Z Lebensm Unters Forsch. 1998;206:259-263.
221. Shihabi ZK, Kute TE. Analysis of cathepsin D from breast tissues by capillary electrophoresis. J. Chromat B. 1996;683:125-131.
222. Chu Q, Jones S, Zeece M. Capillary electrophoretic determination of cathepsin D activity using Oregon Green-labeled hemoglobin. Electrophoresis. 1999;20:2945-2951.
223. Fu S, Chu SG, Qin ZF, Xu XB. Determination of cathepsin D activity in MCF-7 cells by capillary zone electrophoresis with on-column sample stacking. Chromatographia. 2003;58:73-78.
224. Tung CH, Bredow S, Mahmood U, Weissleder R. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjugate Chem. 1999;10:892-896.
225. Dolbeare FA, Smith RE. Flow cytometric measurement of peptidases with use of 5-nitrosalicylaldehyde and 4-methoxy-b-naphthylamine derivatives. Clin Chem. 1977;23:1485-1491.
226. Rothe G, Klingel S, Assfalg-Machleidt I, Machleidt W, Zirkelbach C, Banati RB, Mangel WF, Valet G. Flow cytometric analysis of protease activities in vital cells. Biol Chem HS. 1992;373:547-554.
227. Llorente L, Richaud-Patin Y, Diaz-Borjon A, Jakez- Ocampo J, Alvarado de la Barrera C. Increased collagenase and dipeptidyl peptidase I activity in leucocytes from healthy elderly people. Clin Exp Immunol. 1999;116:425-429.
228. Llorente L, de la Fuente H, Richaud-Patin Y, Alvarado de la Barrera C, Diaz-Borjon A, Lopez-Ponce A, Lerman-Garber I, Jakez- Ocampo J. Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology. Immunol Lett. 2000;74:239-244.
229. de la Fuente H, Richaud-Patin Y, Jakez- Ocampo J, Gonzalez-Amaro R, Llorente L. Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE). Immunol Lett. 2001;77:175-180.
230. Ravdin PM, Tandon AK, Allred DC. Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol. 1994;12:468-474.
231. Schultz DC, Bazel S, Wright LM, Tucker S, Lange MK, Tachovsky T, Longo S, Alhadeff JA. Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls. Canc Res. 1994;54:48-54.
232. Laury-Kleintop LD, Coronel EC, Lange MK, Tachovsky T, Longo S, Tucker S, Alhadeff JA. Western blotting and isoform analysis of cathepsin D from normal and malignant human breast cell lines. Breast Canc Res Treat. 1995;35:211-220.
233. Yokota S, Tsuji H, Kato K. Immunocytochemical localization of cathepsin D in lysosomes of cortical collecting tubule cells of the rat kidney. J Histochem Cytochem. 1985;33:191-200.
234. Mort JS, Poole AR, Decker RS. Immunofluorescent localization of cathepsin B and D in human fibroblasts. J Histochem Cytochem. 1981;29:649-657.
235. Yamato S, Hirabayashi Y, Sugihara H, Uematsu H. Electron microscopic visualization of cathepsin D using mercury-labeled pepstatin as an enzyme inhibitor. J Histochem Cytochem. 1982;30:1228-1234.
236. Goto T, Kiyoshima T, Moroi R, Tsukuba T, Nishimura Y. Himeno M, Yamamoto K, Tanaka T. Localization of cathepsins B, D, and L in the rat osteoclast by immuno-light and-electron microscopy. Histochemistry. 1994;101:33-40.